• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.08% Nasdaq Down0.35%

    Alnylam Pharmaceuticals, Inc. (ALNY)

    59.22 Down 1.39(2.29%) Feb 9, 4:00PM EST
    |After Hours : 59.22 0.00 (0.00%) Feb 9, 5:35PM EST
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):1.9
    Mean Recommendation (last week):1.9

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:144.42
    Median Target:147.00
    High Target:184.00
    Low Target:107.00
    No. of Brokers:12

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Jan 20, 2016Credit SuisseInitiated Outperform
    Oct 23, 2015JefferiesInitiated Buy
    Aug 11, 2015FBR CapitalInitiated Outperform
    Aug 7, 2015JP MorganDowngradeOverweightNeutral
    Mar 4, 2015BarclaysInitiated Overweight
    Feb 11, 2013MLV & CoDowngradeBuyHold
    Oct 14, 2011Rodman & RenshawInitiated Mkt Outperform
    May 6, 2011MLV CapitalInitiated Buy
    May 20, 2010ThinkEquityInitiated Buy
    Nov 24, 2009Roth CapitalDowngradeBuyHold

    More Upgrades & Downgrades for ALNY

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy4443

    Data provided by Thomson/First Call

    Currency in USD.